Vectura Group

From Wikipedia, the free encyclopedia

Vectura Group plc
TypePublic
LSE: VEC
IndustryPharmaceuticals
Founded1997
HeadquartersChippenham, England, UK
Number of locations
5 (2019)
Key people
Bruno Angelici, Chairman
Will Downie, (CEO)
RevenueIncrease £190.6 million (2020)[1]
Increase £132.8 million (2020)[1]
Increase £122.4 million (2020)[1]
Number of employees
450 (2021)[2]
Websitewww.vectura.com Edit this at Wikidata

Vectura Group plc is a British pharmaceuticals business based in Chippenham, England. It was listed on the London Stock Exchange until it was acquired by Philip Morris International in September 2021.

History[]

The company was formed in 1997 as a start-up pharmaceuticals business.[3] In 1999 it acquired Co-ordinated Drug Development and the Centre for Drug Formulation Studies.[3] In 2004 it was listed on the Alternative Investment Market.[3] In 2007 it acquired Innovata plc, another developer of pulmonary products,[4] and then moved onto the full list of the London Stock Exchange.[3] It acquired Activaero, a German manufacturer in the same sector, for £108 million in March 2014.[5] On 10 June 2016 Vectura completed a £441 million merger with Skyepharma, a maker of devices such as asthma inhalers; it was announced that the merged company would continue to be known as Vectura.[6]

In July 2021, American tobacco company Philip Morris International made an offer to buy Vectura Group for £1 billion.[7] The Carlyle Group, an American private equity firm, also submitted an offer which was £44m lower.[8] The board subsequently accepted the offer from Philip Morris International[9] and, in September 2021, the company confirmed that circa 75% of shareholders had supported the takeover.[10]

Operations[]

The group is a developer of inhaled therapies for the treatment of respiratory diseases.[11]

References[]

  1. ^ a b c "Annual Results 2020" (PDF). Vectura Group. Retrieved 18 March 2021.
  2. ^ "Executing on our inhaled specialist CDMO strategy" (PDF). Vectura Group. 14 January 2021. Retrieved 3 March 2021.
  3. ^ a b c d "History". Vectura Group. Retrieved 3 August 2016.
  4. ^ Vectura buys Innovata Guardian, 17 November 2006
  5. ^ "UK's Vectura buys Activaero for £108 million". Pharma Times. 16 March 2014. Retrieved 20 June 2015.
  6. ^ Bradshaw, Julia (16 March 2016). "Vectura and Skyepharma to merge in £441m deal". The Daily Telegraph. Retrieved 11 June 2016.
  7. ^ Ralph, Alex (9 July 2021). "Philip Morris buys respiratory drugs company Vectura for £1bn". The Times. ISSN 0140-0460. Retrieved 9 July 2021.
  8. ^ "Health firm Vectura faced with choice between Carlyle and Philip Morris". the Guardian. 10 August 2021.
  9. ^ "Vectura board unanimously accepts Philip Morris's controversial takeover bid". The Guardian. 12 August 2021. Retrieved 17 September 2021.
  10. ^ "Philip Morris seals deal for UK's Vectura despite health group concerns". Reuters. 16 September 2021. Retrieved 21 September 2021.
  11. ^ "Dr Karl Keegan to join Vectura Group". Manufacturing Chemist. Retrieved 20 June 2015.

External links[]

Retrieved from ""